ARCHIVES

Phase III Trial: Panobinostat Increases PFS by Four Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

AACR Supports 5 Percent Increase in NCI Budget.

April 7, 2006

Gene Variant Associated With 44 Percent Cancer Risk Reduction

October 26, 2012

Studies Shed Light On Racial Disparities Between Blacks, Whites With Breast Cancer

July 31, 2009

NCI Director Says Gallo’s Work On HIV Should Have Been Recognized.

October 10, 2008

NCI spends A Third Of Its Budget On Prevention

May 15, 1992

In Brief: Wells Tapped For GM Cancer Foundation; Calder Named NABCO Associate Director

January 17, 1997